Facebook
Twitter
LinkedIn
ForwardWorld of Phlebology (CONG2014-18)
This course includes the following:
Anticoagulants: State of the Art/News
Jack Ansell, MD
Anticoagulants: International Recommendations
Gary Raskob, PhD
Anticoagulants: Discussion by World Representatives/Experts
Jack Ansell, MD
Alessandro Frullini, MD
Gary Raskob, PhD
Anticoagulants: Question and Answer
Jack Ansell, MD
Alessandro Frullini, MD
Gary Raskob, PhD
Sclerosants: State of the Art/News
Eberhard Rabe, MD
Sclerosants: International Recommendations
Alessandro Frullini, MD
Sclerosants: Discussion by World Representatives/Experts
Alessandro Frullini, MD
Jean-Jerome Guex, MD, FACPh
Eberhard Rabe, MD
Sclerosants: Question and Answer
Alessandro Frullini, MD
Jean-Jerome Guex, MD, FACPh
Eberhard Rabe, MD
Steps to Successfully Complete This Activity
To participate in this educational activity please follow the steps listed below.
If you are new to the ACP Online Education Center we require that you register prior to viewing any activity. Click the Register link located in the top right corner of this screen to do so. If you are already a registered user log in and click the TAKE COURSE button that will appear in the Course Summary box.
- To begin the activity click the START COURSE button.
- Progress through course content by using the NEXT button.
- Complete all required items in the course.
- Track your progress using the Course Progress menu.
- On the final page of the activity a link will be provided to download your certificate.
Target Audience
The content of this activity is designed to meet the needs of the following target audience: phlebologists, general surgeons, vascular surgeons, interventional radiologists, interventional cardiologists, vascular medicine practitioners, dermatologists, dermatologic surgeons, family practice and internal medicine practitioners, plastic surgeons, obstetricians and gynecologists, cardiologists, and any other healthcare professional currently or planning on treating patients with venous disease.
| NAME | ROLE | COMMERCIAL INTEREST | TYPE OF RELATIONSHIP |
|---|---|---|---|
| Jack Ansell, MD | Speaker | Bristol Myers Squibb Pfizer Boehringer Ingelheim Daiichi Sankyo Perosphere Inc. | Consultant; Speaker Consultant; Speaker Consultant; Speaker Consultant Consultant |
| Catherine Burdge, APRN | Content Reviewer | None | n/a |
| Yung-Wei Chi, DO, FAHA, FSVM | Planner | None | n/a |
| Alessandro Frullini, MD | Speaker | Baldaccilab | Consultant |
| Jean-Jerome Guex, MD, FACPh | Moderator; Speaker | Innotech Thuasne Vascular Insights Servier | Principal Investigator Investigator; Consultant Consultant Consultant; Speaker; Writer |
| Sanjoy Kundu, MD, FSIR, FASA, DABR, FCIRSE | Content Reviewer | None | n/a |
| Stephen H. Moss | Staff | None | n/a |
| Eric Mowatt-Larssen, MD, FACPh, RPhS | Content Reviewer | None | n/a |
| Eberhard Rabe, MD | Speaker | None | n/a |
| Gary Raskob, PhD | Speaker | Daiichi Sankyo BMS Bayer Healthcare Janssen Pharmaceuticals Pfizer Johnson and Johson | Consultant Consultant Consultant Consultant Consultant Consultant |
| Saundra Spruiell, DO, FACPh, RPVI | Planner | None | n/a |
Disclaimer
The views and opinions expressed in this activity are those of the faculty and do not necessarily represent the views of the ACP. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic skills in applying or adopting professional use of any of the information provided herein. Links to other sites may be provided as additional sources of information. Once you elect to link to a site outside of ACP Education you are subject to the terms and conditions of use, including copyright and licensing restriction, of that site.
Discussion of Off-Label Use
Although no longer required by the Accreditation Council for Continuing Medical Education (ACCME), ACP CME requests all faculty to inform learners of any products they will discuss that are off-label or investigational.
Reproduction Prohibited
Reproduction of this material is not permitted without written permission from the copyright owner.